The Rebleeding Course and Long-Term Outcome of Esophageal Variceal Hemorrhage after Ligation: Comparison with Sclerotherapy

References

• Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800–9.
   PubMed Web of Science ®Google Scholar
• Christensen E, Fauerholdt L, Schlichting P, Juhl E, Poulsen H, Tygstrup N, et al. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisolone. Gastroenterology 1981;81:944–52.
   PubMed Web of Science ®Google Scholar
• Larson AW, Cohen H, Zweiban B, Chapman D, Gourdji M, Korula J, et al. Acute esophageal variceal sclerotherapy: results of a prospective randomized controlled trial. JAMA 1986;255:497–500.
   PubMed Web of Science ®Google Scholar
• Westaby D, Hayes PC, Gimson AES, Polson RJ, Williams R. Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology 1989;9:274–7.
   Google Scholar
• Terblanche J, Bornman P, Kahn D, Jonker MA, Campbell JAH, Wright J, et al. Failure of repeated injection sclerotherapy to improve long-term survival after esophageal variceal bleeding. Lancet 1983;2:1328–33.
   PubMed Web of Science ®Google Scholar
• Korula J, Balart LA, Radvan G, Zweiban BE, Larson AW, Kao HW, et al. A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy. Hepatology 1985;5:584–9.
   PubMed Web of Science ®Google Scholar
• Copenhagen Esophageal Varices Sclerotherapy Project. Sclerotherapy after first variceal hemorrhage in cirrhosis. N Engl J Med 1984;311:1594–600.
   PubMed Web of Science ®Google Scholar
• Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula L, Lieberman D, Saeed ZA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992;326:1527–32.
   Google Scholar
• Gimson AES, Ramage JK, Panos MZ, Hayllar K, Harrison PM, Williams R, et al. Randomized trial of variceal banding ligation versus injection sclerotherapy for bleeding esophageal variceal. Lancet 1993;342:391–4.
   PubMed Web of Science ®Google Scholar
• Laine L, El-Newihi HM, Migikovsky B, Sloane R, Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 1993;119:1–7.
   PubMed Web of Science ®Google Scholar
• Hou MC, Lin HC, Kuo BIT, Chen CH, Lee FY, Lee SD. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology 1995;21:1517–22.
   PubMed Web of Science ®Google Scholar
• Williams SGJ, Westaby D. Recent advances in the endoscopic management of variceal bleeding. In: De Franchis R, editor. Portal hypertension. II. Proceedings of the Second Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science Ltd.; 1996. p. 114–25.
   Google Scholar
• Sauerbruch T, Weinzierl M, Ansari H, Paumgartner G. Injection sclerotherapy of esophageal variceal hemorrhage. A prospective long-term follow-up study. Endoscopy 1987;19:181–4.
   Google Scholar
• Kokawa H, Shijo H, Kubara K, Nakaoka K, Toriya H, Shirai Z, et al. Long-term risk factors for bleeding after first course of endoscopic injection sclerotherapy: a univariate and multivariate analysis. Am J Gastroenterol 1993;88:1206–11.
   PubMed Web of Science ®Google Scholar
• Baronchi D, Milandri GL, Borioni D, Piemontese A, Cennamo V, Billi P, et al. A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices. Endoscopy 1997;29:235–40.
   PubMed Web of Science ®Google Scholar
• Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981;27:213–8.
   PubMed Web of Science ®Google Scholar
• Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg 1973;60:646–9.
   PubMed Web of Science ®Google Scholar
• Kitano S, Iso Y, Yamaga H, Hashizume M, Higashi H, Sugimachi K. Trial of sclerosing agents in patients with esophageal varices. Br J Surg 1988;75:751–3.
   PubMed Web of Science ®Google Scholar
• Jensen DM. Sclerosants for injection sclerosis of esophageal varices. Gastrointest Endosc 1983;29:315–7.
   PubMed Web of Science ®Google Scholar
• Sarin SK, Govil A, Jain AK, Guptan RC, Issar SK, Jain M, et al. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol 1997;26:826–32.
   PubMed Web of Science ®Google Scholar
• Westaby D, Melia W, Hegarty J, Gimson AES, Stellon AJ, Williams R. Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology 1986;6:673–5.
   PubMed Web of Science ®Google Scholar
• Madonia S, Traina M, Montalbano L, D’Amico G. Variceal ulceration following sclerotherapy: normal consequence or complication? Gastrointest Endosc 1990;36:76–7.
   Google Scholar
• Tabibian N, Smith LJ, Graham DY. Sclerotherapy-associated esophageal ulcers: lessons from a double-blind, randomized comparison of sucralfate suspension versus placebo. Gastrointest Endosc 1989;35:312–5.
   Google Scholar
• Yang WG, Hou MC, Lin HC, Kuo BIT, Lee FY, Chang FY, et al. Effects of sucralfate granules in suspension on endoscopic variceal sclerotherapy induced ulcer: analysis of the factors determining ulcer healing. J Gastroenterol Hepatol 1998;13:225–31.
   PubMed Web of Science ®Google Scholar
• Stiegmann GV, Sun JH, Hammond WS. Results of experimental endoscopic esophageal varix ligation. Am Surg 1988;54:105–8.
   Google Scholar
• Leung VkS, Sung JJY, Ahuja AT, Tumala IE, Lee YT, Lau JYW, et al. Large paraesophageal varices on endosonography predict recurrence of esophageal varices and rebleeding. Gastroenterology 1997;112:1811–6.
   Google Scholar
• Prindiville T, Miller M, Trudeau W. Prognostic indictors in acute variceal hemorrhage after treatment by sclerotherapy. Am J Gastoenterol 1987;82:655–9.
   Google Scholar
• Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tammasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:676–80.
   Web of Science ®Google Scholar
• Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, et al. Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B. Hepatology 1995;21:77–82.
   Google Scholar
• Liaw YF, Lin Dy, Chen TJ, Chu CM. Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Liver 1989;9: 235–41.
   Google Scholar
• Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomized trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051–5.
   PubMed Web of Science ®Google Scholar
• Ng WD, Chan YT, Ho KK, Kong CK. Injection sclerotherapy for bleeding esophageal varices in cirrhotic patients with hepatocellular carcinoma. Gastrointest Endosc 1989;35:69–70.
   PubMed Web of Science ®Google Scholar